Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Recommendations for GERD Management

Clin Gastroenterol Hepatol; ePub 2017 Aug 4; Gyawali, et al

Publish date:: August 24, 2017

The management of gastroesophageal reflux disease (GERD) should start with empiric proton pump inhibitors (PPIs) in combination with lifestyle choices in patients without alarm symptoms, according to a recent review. Additional recommendations include:

Improving the therapeutic regimen by improving compliance and timing of PPI doses.
Increasing PPI doses to twice daily in certain patients to reduce persistent symptoms.
Endoscopy should be considered in patients who continue to have symptoms.

Citation:

Gyawali CP, Fass R. Management of gastroesophageal reflux disease. [Published online ahead of print August 4, 2017]. Clin Gastroenterol Hepatol. doi:10.1053/j.gastro.2017.07.049.

This Week's Must Reads

Younger adults present with more advanced esophageal adenocarcinoma,

PDAC: Tumor reduction after neoadjuvant therapy may predict postsurgical survival,

Endoscopic intragastric balloon improved NASH parameters,

Autologous fecal microbiota transplantation helped maintain weight loss after ‘green’ Mediterranean diet,

Cryoballoon, cryospray found equivalent for eradicating Barret’s esophagus,

Must Reads in Upper GI Tract

Younger adults present with more advanced esophageal adenocarcinoma,

Cryoballoon, cryospray found equivalent for eradicating Barret’s esophagus,

Budesonide orodispersible tablets maintained remissions in EoE,

Trial of epicutaneous immunotherapy in eosinophilic esophagitis,

Gastric electrical stimulation device may improve refractory vomiting,